Cost-Effectiveness of Intensive Cancer Screening Among Colorectal Cancer Survivors |
Jennifer Elston-Lafata |
Henry Ford Health System |
PLCO |
Jul 1, 2006 |
2006-0074 |
Cost of Screen-Induced Diagnostic Evaluation |
Jennifer Elston-Lafata |
Henry Ford Health System |
PLCO |
Jul 1, 2006 |
2006-0075 |
Tuberculosis and Scarring as Risk Factors for Lung Cancer |
Eric Engels |
NCI, DCEG, VEB |
PLCO |
Jul 1, 2006 |
2006-0078 |
Vitamin C and Polymorphisms in Genes Related to Vitamin C Transport and Risk of Prostate Cancer and Colorectal Adenoma in the PLCO Trial |
Hans Erichsen |
NCI, CCR, POB |
PLCO |
Jul 1, 2006 |
2006-0079 |
Colorectal Adenoma -Dietary Factors Glycemic Index/ Glycemic Load |
Andrew Flood |
University of Minnesota |
PLCO |
Jul 1, 2006 |
2006-0082 |
Examining the Effects of a False Positive Result on Subsequent Cancer Screening Behavior |
Marvella Ford |
Medical University of South Carolina Hollings Cancer Center |
PLCO |
Jul 1, 2006 |
2006-0088 |
Understanding Factors Related to Prostate, Lung, and Colorectal Cancer Screening Among African American Men |
Marvella Ford |
Medical University of South Carolina Hollings Cancer Center |
PLCO |
Jul 1, 2006 |
2006-0089 |
Recruiting African American Men to the HFHS PLCO Cancer Screening Trial: The AAMEN Study |
Marvella Ford |
Medical University of South Carolina Hollings Cancer Center |
PLCO |
Jul 1, 2006 |
2006-0090 |
AAMEN Study Outcomes |
Marvella Ford |
Medical University of South Carolina Hollings Cancer Center |
PLCO |
Jul 1, 2006 |
2006-0091 |
Patterns of Follow-up Evaluation for Positive Screening Exams |
Mona Fouad |
University of Alabama at Birmingham |
PLCO |
Jul 1, 2006 |
2006-0092 |
Lung Scarring and Pulmonary Fibrosis Among Abnormal Suspicious Lung Screens |
Matthew Freedman |
Georgetown University |
PLCO |
Jul 1, 2006 |
2006-0093 |
Study of Effectiveness of Computer Aided Detection of Missed Cancers |
Matthew Freedman |
Georgetown University |
PLCO |
Jul 1, 2006 |
2006-0095 |
A Randomized Study to Determine Effectiveness of Interventions to Improve Participant Compliance in a Large Screening Trial |
Sheryl Ogden |
University of Colorado Health Sciences Center |
PLCO |
Jul 1, 2006 |
2006-0096 |
Study of Aberrant Crypt Foci (ACF) |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Jul 1, 2006 |
2006-0099 |
Colorectal Adenoma -Dietary Factors Dietary Supplements |
Mia Gaudet |
American Cancer Society |
PLCO |
Jul 1, 2006 |
2006-0100 |
Influence of a Structural Polymorphism in a Prostate-Specific Homeobox Protein on Prostate Size. (NKX3.1 and BPH) |
Edward Gelmann |
Georgetown University |
PLCO |
Jul 1, 2006 |
2006-0101 |
Development of Criteria and Standards for Use of Biorepository Specimens |
Edward Gelmann |
Georgetown University |
PLCO |
Jul 1, 2006 |
2006-0105 |
Relationship of Demographic and Clinical Factors to Free and Total Prostate-Specific Antigen (original title: Free PSA (Patterns of Age and Race Specific Values of Free + Total PSA)) |
Edward Gelmann |
Georgetown University |
PLCO |
Jul 1, 2006 |
2006-0106 |
Colorectal Adenoma Other Factors -Alcohol |
Regina Ziegler |
NCI, DCEG, EBP |
PLCO |
Jul 1, 2006 |
2006-0109 |
The Association of Family History and SES with Advanced/Aggressive Prostate Tumors in PLCO |
Robert Greenlee |
Marshfield Clinic Research Foundation |
PLCO |
Jul 1, 2006 |
2006-0113 |